250
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Therapy strategy in tumour cells and immune system interaction mathematical model

&
Pages 1548-1559 | Received 01 Oct 2015, Accepted 09 Feb 2016, Published online: 01 Mar 2016
 

Abstract

In this paper, we propose a method to optimise a theoretical control on a mathematical model of interactions between cancer cells and the immune system. The model consists of five ordinary differential equations describing the behaviour of a tumour cell population interacting with populations of immune cells, all cells being submitted to the effects of chemotherapy. Two constraints were added to reflect the biological specificity of the problem. The first one asserts that the number of cytotoxic T lymphocytes must remain above a given threshold at the terminal point in time. The second one keeps the drug concentration in the bloodstream below a threshold to reduce toxic side effects resulting from the damages of chemotherapy to healthy cells. Using Pontryagin’s Maximum Principle and approximation methods for optimal control, we obtain bang–bang solutions for different scenarios.

AMS Subject Classifications:

Notes

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Federal targeted program of the Russian Federation [grant number RFMEFI57814X0030].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.